Loading...
Cyclophosphamide — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Cyclophosphamide
2025-Q4
Comprehensive analysis of India’s cyclophosphamide export trade — suppliers, buyers, prices, routes, and every shipment record.
221
Shipments
$2.95M
Trade Value
78
Suppliers
61
Buyers
53
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/cyclophosphamide
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s cyclophosphamide trade — 2025-Q4
KEY TAKEAWAY
Cyclophosphamide 2025-Q4 exports total $2.9M across 53 countries, with EUGIA PHARMA SPECIALITIES LTD commanding 90.2% market share.
TOTAL SHIPMENTS
221
2025-Q4
EXPORT VALUE
$2.9M
FOB USD
TOTAL QUANTITY
1.2M
units shipped
INDIAN SUPPLIERS
78
unique exporters
GLOBAL BUYERS
61
unique importers
DESTINATIONS
53
countries
MEDIAN UNIT PRICE
$0.719
per unit
TOP-5 SHARE
97.2%
of total USD
BRANDED SHARE
57.9%
128 shipments
DOSAGE FORMS
8
product types
6 KEY FINDINGS
1
EUGIA PHARMA SPECIALITIES LTD is India's #1 Cyclophosphamide exporter with $2.7M (90.2% market share).→ §5, Indian Supplier Rankings
2
Cyclophosphamide reached 53 countries, with United States as the top destination ($2.8M).→ §4, Global Destination Map
3
Market concentration is high (HHI: 8156) — top 10 suppliers control 98.9% of exports.→ §5, Indian Supplier Rankings
4
96.7% of buyers (59 of 61) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Injection dominates (94.8%) across 8 dosage forms.→ §7, Price Benchmarks
6
51 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 EUGIA PHARMA SPECIALITIES LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian cyclophosphamide exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Cyclophosphamide report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial cyclophosphamide trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian cyclophosphamide suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Cyclophosphamide India trade report
Product scope
Cyclophosphamide
All variants merged — branded and generic formulations of cyclophosphamide
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
221
Every commercial cyclophosphamide trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $2.7M, Nov $223.2K, Dec $40.8K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$2.7M
Oct USD
17 shipments
2
$223.2K
Nov USD
-91.7% MoM
3
$40.8K
Dec USD
-81.7% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 91.7% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $2.7M, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $2.9M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $2.5M dip in Nov, $182K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $2.7M | 17 shipments |
| Nov | $223K | 81 shipments |
| Dec | $41K | 123 shipments |
| Q4 Total | $2.9M | 221 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United Arab Emirates held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: EUGIA PHARMA SPECIALITIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import cyclophosphamide from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 93.8% of India’s 2025-Q4 cyclophosphamide trade ($2.8M). Beyond the top 10 destinations, 51 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 20 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 51 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much cyclophosphamide India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$50K
1.7% of trade
16 countries · 80 shipments
Europe
$16K
0.5% of trade
2 countries · 4 shipments
Americas
$2.8M
96.2% of trade
14 countries · 54 shipments
Africa
$46K
1.5% of trade
20 countries · 81 shipments
Oceania
$240
0.0% of trade
1 countries · 2 shipments
Fig 4.1 United States is the #1 corridor ($2.8M) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian cyclophosphamide it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $2.8M | 6 | EUGIA PHARMA SPECIALITIES LTD | $2.7M | ALEMBIC PHARMACEUTICALS LTD | $106K | — | — |
| 2 | Mexico | $30K | 21 | KWALITY PHARMACEUTICALS LTD | $21K | MYGENIC HEALTHCARE PVT LTD | $7K | VAMA HEALTH WORLD LLP | $2K |
| 3 | Venezuela | $27K | 2 | AMRS HEALTHCARE PVT LTD | $27K | — | — | — | — |
| 4 | Mali | $23K | 1 | PEACOCK MEDICINE COMPANY | $23K | — | — | — | — |
| 5 | Nepal | $17K | 10 | INDOCO REMEDIES LTD | $16K | GETWELL PHARMA INDIA PVT LTD | $1K | UNITED BIOTECH PVT LTD | $394 |
| 6 | Moldova | $16K | 3 | KWALITY PHARMACEUTICALS LTD | $16K | — | — | — | — |
| 7 | Afghanistan | $15K | 6 | KWALITY PHARMACEUTICALS LTD | $14K | KERK | $966 | MEDMATRIX ASSOCIATES | $61 |
| 8 | Madagascar | $8K | 4 | GETWELL PHARMA INDIA PVT LTD | $8K | — | — | — | — |
| 9 | Ecuador | $7K | 2 | SUBHRA PHARMA PRIAVATE LTD | $7K | — | — | — | — |
| 10 | Philippines | $6K | 4 | GETWELL PHARMA INDIA PVT LTD | $5K | MALLESHWAR SPECIALITIES | $1K | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 1.7% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
93.8%
#1 country share
United States alone
97.1%
Top 5 share
5 of 53 countries
99.4%
Top 15 share
Long tail of 38 countries = 0.6%
HHI 8801
Destination HHI
Highly concentrated
53
Countries served
Global pharma reach from India
20
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
78 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
EUGIA PHARMA SPECIALITIES LTD ($2.7M, 90.2% share) and ALEMBIC PHARMACEUTICALS LTD ($105.7K) together control 93.8% of India’s 2025-Q4 cyclophosphamide trade. The top 5 suppliers hold 97.2%. 78 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian cyclophosphamide suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 EUGIA PHARMA SPECIALITIES LTD leads by $2.6M over ALEMBIC PHARMACEUTICALS LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: VAMA HEALTH WORLD is #17 by value but #2 by volume.
Fig 5.2 GETWELL PHARMA INDIA PVT LTD also leads by shipment count (13) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: VAMA HEALTH WORLD moves from #2 by volume to #17 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 78 cyclophosphamide suppliers split into strategic segments
KEY TAKEAWAY
20 suppliers (25%) generate 99.5% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 EUGIA PHARMA SPECIALITIES LTD and ALEMBIC PHARMACEUTICALS LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.5% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | KWALITY PHARMACEUTICALS LTD | 2 | 3 | $51K |
| 2 | INDOCO REMEDIES LTD | 2 | 1 | $16K |
| 3 | MYGENIC HEALTHCARE PVT LTD | 2 | 1 | $7K |
| 4 | VAMA HEALTH WORLD LLP | 2 | 2 | $2K |
| 5 | EUGIA PHARMA SPECIALITIES LTD | 1 | 1 | $2.7M |
| 6 | ALEMBIC PHARMACEUTICALS LTD | 1 | 1 | $106K |
| 7 | AMRS HEALTHCARE PVT LTD | 1 | 1 | $27K |
| 8 | PEACOCK MEDICINE COMPANY | 1 | 1 | $23K |
| 9 | GETWELL PHARMA INDIA PVT LTD | 1 | 6 | $16K |
| 10 | SUBHRA PHARMA PRIAVATE LTD | 1 | 2 | $7K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the cyclophosphamide manufacturing hubs
KEY TAKEAWAY
Medchal Malkajigiri Dist and Gujarat together account for $2.8M of India’s 2025-Q4 cyclophosphamide trade.
Fig 5.5 Medchal Malkajigiri Dist (1 exporters, $2.7M) and Gujarat (1 exporters, $106K) are India’s cyclophosphamide capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
97.2%
Top 5 share
5 of 78 suppliers
98.9%
Top 10 share
10 of 78 suppliers
99.5%
Top 25% share
20 suppliers = 100% USD
HHI 8156
Supplier HHI
Concentrated
78
Total suppliers
shipped Cyclophosphamide in 2025-Q4
20+ cities
Indian hubs
Medchal Malkajigiri Dist and Gujarat lead
§5.2 Coming next: 5 exporter deep-dive profiles
Each of the top 5 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | KWALITY PHARMACEUTICALS LTD | $51K |
| #2 | GETWELL PHARMA INDIA PVT LTD | $16K |
| #3 | UNITED BIOTECH PVT LTD | $5K |
| #4 | VAMA HEALTH WORLD LLP | $2K |
| #5 | SANSKRUTI PHARMA | $739 |
#3
EXPORTER PROFILE #1 OF 5
KWALITY PHARMACEUTICALS LTD
Amritsar · India’s #3 cyclophosphamide supplier by USD · 2025-Q4
2025-Q4 USD
$51K
1.7% market share
SHIPMENTS
7
avg $7K/ship
COUNTRIES
3
destination markets
BUYERS
4
3 single-sourced
BRANDED
14%
of shipments
DOSAGE FORMS
2
product types
TOP 3 DESTINATIONS
Mexico is the #1 market at $21K (41% of trade), followed by Moldova at $16K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Mexico | $21K | 1 | 40.9% |
| 2 | Moldova | $16K | 3 | 31.5% |
| 3 | Afghanistan | $14K | 3 | 27.7% |
MONTHLY TREND
Nov peaked at $30K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 79% of trade. Tablet (20.8%) and others are secondary formulations.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| ACCESORIOS SUMINISTROS… | Mexico | $21K | ⚠ Locked |
| TRUST ANESTHETIC LTD | Afghanistan | $14K | ⚠ Locked |
| DITA ESTFARM LLC | Moldova | $8K | ⚠ Locked |
| Undisclosed buyer | Moldova | $8K | N/A |
#3
EXPORTER PROFILE #1 OF 5 — TRADE FLOW MAP
KWALITY PHARMACEUTICALS LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P1.3 Mexico absorbs $21K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 2 importers per destination.
#6
EXPORTER PROFILE #2 OF 5
GETWELL PHARMA INDIA PVT LTD
Gurgaon · India’s #6 cyclophosphamide supplier by USD · 2025-Q4
2025-Q4 USD
$16K
0.5% market share
SHIPMENTS
13
avg $1K/ship
COUNTRIES
6
destination markets
BUYERS
7
7 single-sourced
BRANDED
92%
of shipments
DOSAGE FORMS
1
product types
TOP 6 DESTINATIONS
Madagascar is the #1 market at $8K (52% of trade), followed by Philippines at $5K. 6 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Madagascar | $8K | 4 | 52.2% |
| 2 | Philippines | $5K | 1 | 32.7% |
| 3 | Jamaica | $1K | 2 | 7.6% |
| 4 | Nepal | $1K | 3 | 6.8% |
| 5 | Mongolia | $106 | 1 | 0.7% |
| 6 | Trinidad and Tobago | $5 | 2 | 0.0% |
MONTHLY TREND
Nov peaked at $16K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 67% of trade. Unknown (32.7%) and others are secondary formulations.
TOP BUYERS · 7/7 LOCKED IN
7 of 7 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| CENTRALE DACHATS DE ME… | Madagascar | $8K | ⚠ Locked |
| AMBICA INTERNATIONAL C… | Philippines | $5K | ⚠ Locked |
| RECHARGED DISTRIBUTORS… | Jamaica | $1K | ⚠ Locked |
| VISION CARE INTERNATIO… | Nepal | $1K | ⚠ Locked |
| TSOMBO LLC | Mongolia | $106 | ⚠ Locked |
| SUNCREST INTERNATIONAL… | Trinidad and Tobago | $5 | ⚠ Locked |
| HANITRA RAZAOARIMANANA | Madagascar | $2 | ⚠ Locked |
#6
EXPORTER PROFILE #2 OF 5 — TRADE FLOW MAP
GETWELL PHARMA INDIA PVT LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P2.3 Madagascar absorbs $8K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#10
EXPORTER PROFILE #3 OF 5
UNITED BIOTECH PVT LTD
New Delhi · India’s #10 cyclophosphamide supplier by USD · 2025-Q4
2025-Q4 USD
$5K
0.2% market share
SHIPMENTS
5
avg $1K/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
20%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Nicaragua is the #1 market at $5K (93% of trade), followed by Nepal at $394. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Nicaragua | $5K | 2 | 92.8% |
| 2 | Nepal | $394 | 3 | 7.2% |
MONTHLY TREND
Nov peaked at $5K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 96% of trade. Unknown (4.4%) and others are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| CORPORACION FARMACEUTI… | Nicaragua | $5K | ⚠ Locked |
| NIKHIL PHARMA PVT LTD | Nepal | $394 | ⚠ Locked |
#10
EXPORTER PROFILE #3 OF 5 — TRADE FLOW MAP
UNITED BIOTECH PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P3.3 Nicaragua absorbs $5K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
#17
EXPORTER PROFILE #4 OF 5
VAMA HEALTH WORLD LLP
Mumbai · India’s #17 cyclophosphamide supplier by USD · 2025-Q4
2025-Q4 USD
$2K
0.1% market share
SHIPMENTS
9
avg $169/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
44%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
Mexico is the #1 market at $2K (100% of trade), followed by Ghana at $3. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Mexico | $2K | 7 | 99.8% |
| 2 | Ghana | $3 | 2 | 0.2% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $2K.
PRODUCT MIX
Injection dominates at 75% of trade. Tablet (24.9%) and others are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| AS PER INVOICE MEXICO | Mexico | $2K | ⚠ Locked |
| AS PER INVOICE GHANA | Ghana | $3 | ⚠ Locked |
#17
EXPORTER PROFILE #4 OF 5 — TRADE FLOW MAP
VAMA HEALTH WORLD LLP — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P4.3 Mexico absorbs $2K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
#24
EXPORTER PROFILE #5 OF 5
SANSKRUTI PHARMA
Surat · India’s #24 cyclophosphamide supplier by USD · 2025-Q4
2025-Q4 USD
$739
0.0% market share
SHIPMENTS
6
avg $123/ship
COUNTRIES
2
destination markets
BUYERS
2
unique importers
BRANDED
83%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Burkina Faso is the #1 market at $695 (94% of trade), followed by Ghana at $45. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Burkina Faso | $695 | 5 | 93.9% |
| 2 | Ghana | $45 | 1 | 6.1% |
MONTHLY TREND
Nov peaked at $737. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 94% of trade. Unknown (6.1%) and others are secondary formulations.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Burkina Faso | $568 | N/A |
| Undisclosed buyer | Burkina Faso | $171 | N/A |
#24
EXPORTER PROFILE #5 OF 5 — TRADE FLOW MAP
SANSKRUTI PHARMA — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P5.3 Burkina Faso absorbs $695 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
61 importers across 53 countries — who is buying Indian cyclophosphamide and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 97.7% of total USD. 97% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian cyclophosphamide. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 EUGIA US LLC is the #1 importer at $2.7M (90.2%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
97%
Single-source
59 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
3%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source cyclophosphamide from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United Arab Emirates 5 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TO THE PURCHASE MANAGE… | REGALIA LIFE SCIENCE… | $760.079 | $3.234 | Injection |
| NOVO GENERAL TRADING FZE | DOSSMEGT PHARMACEUTI… | $259.557 | $0.519 | Injection |
| MEDIMART DRUG STORE | DROPS PHARMA PVT LTD | $211.061 | $1.242 | Tablet |
| BEST INTERNATIONAL FZE | MEDEX PHARMACEUTICALS | $155.235 | $1.035 | Injection |
| TO,THE ORDER OF | ZYPHARS PHARMACEUTIC… | $0.146 | $0.049 | Tablet |
Mexico 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ACCESORIOS SUMINISTROS… | KWALITY PHARMACEUTIC… | $21K | $0.692 | Injection |
| AS PER INVOICE MEXICO | VAMA HEALTH WORLD LLP | $2K | $0.799 | Injection |
| DISTRIBUIDORA MEDICA P… | ATLAS ENTERPRISES | $359.594 | $0.719 | — |
| DISTRIBUIDORA MEDICA P… | ATLAS ENTERPRISES | $8.542 | $0.011 | Powder |
Nepal 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BIRGANJ MEDI SA | INDOCO REMEDIES LTD | $16K | $0.414 | Tablet |
| VISION CARE INTERNATIO… | GETWELL PHARMA INDIA… | $1K | $0.364 | Injection |
| NIKHIL PHARMA PVT LTD | UNITED BIOTECH PVT LTD | $393.964 | $0.492 | — |
Afghanistan 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| TRUST ANESTHETIC LTD | KWALITY PHARMACEUTIC… | $14K | $0.028 | Injection |
| MUBARAK HASHIMI LTD | KERK | $965.877 | $0.322 | Tablet |
| GULF IMPEX FZC | MEDMATRIX ASSOCIATES | $61.224 | $0.306 | Tablet |
Ghana 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PHILTA PHARMACY AND HE… | LIFENEST PHARMA LLP | $432.309 | $0.865 | Other |
| NEW AFRICA SOFTWARE SO… | WELLKIND PHARMACEUTI… | $421.924 | $0.622 | Injection |
| AS PER INVOICE GHANA | VAMA HEALTH WORLD LLP | $2.790 | $0.020 | Injection |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | EUGIA US LLC | United States | $2.7M | $665K | Premium |
| 2 | J. KNIPPER & COMPANY | United States | $106K | $53K | Premium |
| 3 | PHARMACIE POPULAIRE … | Mali | $23K | $23K | Mid |
| 4 | ACCESORIOS SUMINISTR… | Mexico | $21K | $21K | Mid |
| 5 | BIRGANJ MEDI SA | Nepal | $16K | $4K | Budget |
| 6 | TRUST ANESTHETIC LTD | Afghanistan | $14K | $5K | Budget |
| 7 | CENTRALE DACHATS DE … | Madagascar | $8K | $4K | Budget |
| 8 | DITA ESTFARM LLC | Moldova | $8K | $4K | Budget |
| 9 | AMBICA INTERNATIONAL… | Philippines | $5K | $5K | Budget |
| 10 | CORPORACION FARMACEU… | Nicaragua | $5K | $3K | Budget |
| 11 | IC PHARMA LAO CO LTD | Laos | $3K | $3K | Budget |
| 12 | DOMAKS INVESTMENT LTD | Nigeria | $2K | $400.000 | Budget |
| 13 | MOG LOGISTICS LLC | Egypt | $2K | $2K | Budget |
| 14 | AS PER INVOICE MEXICO | Mexico | $2K | $216.000 | Budget |
| 15 | PHARMACHEIME LTD | Malawi | $1K | $1K | Budget |
| 16 | RECHARGED DISTRIBUTO… | Jamaica | $1K | $610.000 | Budget |
| 17 | RENATO C LOZADA | Philippines | $1K | $376.000 | Budget |
| 18 | VISION CARE INTERNAT… | Nepal | $1K | $364.000 | Budget |
| 19 | MUBARAK HASHIMI LTD | Afghanistan | $965.877 | $483.000 | Budget |
| 20 | AUTOMOBILE TRANSPORT… | Lebanon | $952.884 | $953.000 | Budget |
| 21 | TO THE PURCHASE MANA… | United Arab Emirates | $760.079 | $54.000 | Budget |
| 22 | PHILTA PHARMACY AND … | Ghana | $432.309 | $432.000 | Budget |
| 23 | NEW AFRICA SOFTWARE … | Ghana | $421.924 | $211.000 | Budget |
| 24 | NIKHIL PHARMA PVT LTD | Nepal | $393.964 | $131.000 | Budget |
| 25 | GP AVIS AGENCIES INC | Barbados | $382.471 | $382.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 EUGIA PHARMA SPECIALITIES LTD → EUGIA US LLC is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian cyclophosphamide prices vary by supplier, country and dosage form
KEY TAKEAWAY
Cyclophosphamide prices span 66140× ($0.0010 → $66.89). The coefficient of variation is 3.69. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0010 | Lowest observed unit price |
| P5 | $0.0070 | 5th percentile |
| P25 | $0.327 | 25th percentile (Q1) |
| Median | $0.719 | 50th percentile (Q2) |
| P75 | $1.14 | 75th percentile (Q3) |
| P95 | $5.06 | 95th percentile |
| Max | $66.89 | Highest observed unit price |
| Mean | $1.79 | Arithmetic average |
| CV | 369% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 EUGIA PHARMA SPECIALITIES LTD prices at $66.69/unit vs market median $0.719.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. KWALITY PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. EUGIA PHARMA SPECIALITIES Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. ALEMBIC PHARMACEUTICALS LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. PEACOCK MEDICINE COMPANY Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | EUGIA PHARMA SPE… | United States | Injection | 7K | $1.04M | $158.83 | Sterile formulation premium |
| Oct 2025 | EUGIA PHARMA SPE… | United States | Injection | 3K | $530K | $158.35 | Sterile formulation premium |
| Oct 2025 | EUGIA PHARMA SPE… | United States | Injection | 8K | $544K | $66.89 | Sterile formulation premium |
| Oct 2025 | EUGIA PHARMA SPE… | United States | Injection | 8K | $552K | $66.49 | Sterile formulation premium |
| Dec 2025 | REGALIA LIFE SCI… | United Arab Emirates | Injection | 20 | $308.19 | $15.41 | Sterile formulation premium |
| Dec 2025 | REGALIA LIFE SCI… | United Arab Emirates | Injection | 7 | $89.55 | $12.79 | Sterile formulation premium |
| Dec 2025 | ZYPHARS PHARMACE… | Uganda | Tablet | 21 | $155.03 | $7.38 | Specialty / small-batch |
| Nov 2025 | ARYSON HEALTHCAR… | Laos | Injection | 400 | $3K | $6.76 | Sterile formulation premium |
| Dec 2025 | ZYPHARS PHARMACE… | Italy | Tablet | 5 | $30.51 | $6.10 | Specialty / small-batch |
| Nov 2025 | SARA TRADING CORP | Saint Lucia | Tablet | 10 | $53.18 | $5.32 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | RMPL PHARMA LLP | Turkey | Tablet | 100 | $0.101 | $0.0010 | Bulk generic tablet |
| Dec 2025 | J.A. UNITED EXPO… | Egypt | Injection | 353 | $1.37 | $0.0039 | Sterile formulation premium |
| Dec 2025 | DISTINCT IMPEX P… | Jamaica | Tablet | 100 | $0.399 | $0.0040 | Bulk generic tablet |
| Dec 2025 | S. HIMATLAL HEAL… | Ethiopia | Injection | 480 | $2.47 | $0.0051 | Sterile formulation premium |
| Dec 2025 | S. HIMATLAL HEAL… | Ethiopia | Injection | 20 | $0.103 | $0.0051 | Sterile formulation premium |
| Dec 2025 | MDS ENTERPRISES | United Arab Emirates | Injection | 496 | $2.99 | $0.0060 | Sterile formulation premium |
| Dec 2025 | MDS ENTERPRISES | United Arab Emirates | Injection | 4 | $0.024 | $0.0060 | Sterile formulation premium |
| Dec 2025 | J.A. UNITED EXPO… | Egypt | Injection | 100 | $0.615 | $0.0062 | Sterile formulation premium |
| Dec 2025 | KWALITY PHARMACE… | Moldova | Injection | 20K | $125.28 | $0.0063 | Sterile formulation premium |
| Dec 2025 | DISTINCT IMPEX P… | Iraq | Injection | 200 | $1.37 | $0.0068 | Sterile formulation premium |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship cyclophosphamide, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Cyclophosphamide leaves India through 15+ ports. The top 5 (HYDERABAD ICD, HYDERABAD AIR, MUNDRA SEA) handle 98.4% of total USD. ICD moves 2% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 HYDERABAD ICD handles $1.6M — top 15 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 SAVANNAH is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
ICD dominates at 2% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
ICD
$1.6M
53.6% of USD · 2.3% of ships
AIR
$1.2M
42.2% of USD · 89.6% of ships
SEA
$108K
3.7% of USD · 5.9% of ships
ROAD
$18K
0.6% of USD · 2.3% of ships
Fig 8.3 The dominant corridor is HYDERABAD ICD → Sea → N. America ($1.6M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
China is the most concentrated destination (HHI 10000, 1 suppliers). United Arab Emirates is the most competitive (HHI 2780).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 China (HHI 10,000) is the most concentrated — United Arab Emirates (HHI 2,780) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| EUGIA US LLC | United States | EUGIA PHARMA SPE… | $2.7M | 4 | CRITICAL |
| J. KNIPPER & COMPANY | United States | ALEMBIC PHARMACE… | $106K | 2 | HIGH |
| PHARMACIE POPULAIRE … | Mali | PEACOCK MEDICINE… | $23K | 1 | MEDIUM |
| ACCESORIOS SUMINISTR… | Mexico | KWALITY PHARMACE… | $21K | 1 | MEDIUM |
| BIRGANJ MEDI SA | Nepal | INDOCO REMEDIES … | $16K | 4 | MEDIUM |
| TRUST ANESTHETIC LTD | Afghanistan | KWALITY PHARMACE… | $14K | 3 | MEDIUM |
| CENTRALE DACHATS DE … | Madagascar | GETWELL PHARMA I… | $8K | 2 | MEDIUM |
| DITA ESTFARM LLC | Moldova | KWALITY PHARMACE… | $8K | 2 | MEDIUM |
Conclusion: 59 buyers depend on exactly one Indian supplier, representing $2.9M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mexico | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Venezuela | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Mali | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Moldova | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Madagascar | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Ecuador | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Philippines | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Nicaragua | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Ghana | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Laos | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in United States | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit China lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter United States (2 suppliers) | This Q | HIGH |
| A6 | Enter Mexico (5 suppliers) | This Q | MED |
| A8 | Build Mexico distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | United States | Other | 2 | $2.8M | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Mexico | Other | 5 | $30K | 0% | LOW | Low competition (5 suppliers), accessible market |
| 3 | Venezuela | Other | 1 | $27K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Mali | Africa | 1 | $23K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Nepal | Asia | 3 | $17K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 6 | Moldova | Other | 1 | $16K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Afghanistan | Asia | 3 | $15K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 8 | Madagascar | Africa | 1 | $8K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Ecuador | Other | 1 | $7K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Philippines | Asia | 2 | $6K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Nicaragua | Other | 1 | $5K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Laos | Asia | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Nigeria | Africa | 2 | $2K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Bhutan | Asia | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Lebanon | Other | 2 | $2K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 221 2025-Q4 Cyclophosphamide shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/cyclophosphamide
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 221 2025-Q4 cyclophosphamide shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian cyclophosphamide shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
221
across all regions
TOTAL USD
$2.95M
2025-Q4 FOB value
UNITS
1.2M
tablets, capsules, etc.
SUPPLIERS
78
Indian exporters
BUYERS
61
global importers
COUNTRIES
53
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $46K (1.5%), spanning 20 countries.
78 Indian suppliers shipped to 61 buyers across 53 countries — average shipment value $13K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
20 countries · 81 shipments · $46K · 39 Indian suppliers · 23 buyers
SHIPMENTS
81
USD
$46K
COUNTRIES
20
SUPPLIERS
39
BUYERS
23
HHI
2,874
concentrated
Top 20 destination countries in Africa
1
Mali (49.4%)
$23K
2
Madagascar (18.4%)
$8K
3
Ghana (9.6%)
$4K
4
Nigeria (5.4%)
$2K
5
Egypt (3.4%)
$2K
6
Burkina Faso (3.3%)
$1K
7
Malawi (2.9%)
$1K
8
Cameroon (2.5%)
$1K
9
Kenya (1.5%)
$673.90
10
Somalia (1.3%)
$571.07
11
Ethiopia (0.9%)
$407.31
12
Equatorial Guinea (0.4%)
$193.67
13
Uganda (0.3%)
$155.03
14
Burundi (0.3%)
$154.59
15
Republic of the Congo (0.1%)
$38.02
16
Eswatini (0.1%)
$27.12
17
Cote d'Ivoire (0.1%)
$24.75
18
Zambia (0.1%)
$24.22
19
Zimbabwe (0.0%)
$18.57
20
Mozambique (0.0%)
$2.45
Top 30 Indian suppliers into Africa
1
PEACOCK MEDICINE COMPANY
$23K
2
GETWELL PHARMA INDIA PVT LTD
$8K
3
ZUVIUS LIFESCIENCES PVT LTD
$2K
4
S P AND COMPANY
$2K
5
AARIA PHARMACEUTICALS PVT LTD
$2K
6
MATHI ASSOCIATES
$1K
7
KLV HEALTHCARE PVT LTD
$1K
8
CHAWLA MEDICOS
$989.76
9
SANSKRUTI PHARMA
$739.43
10
MENAMED PHARMA PVT LTD
$542.41
11
RMPL PHARMA LLP
$477.08
12
R.S. SURGIPHARM PVT LTD
$471.27
13
LIFENEST PHARMA LLP
$432.31
14
WELLKIND PHARMACEUTICAL PVT LTD
$421.92
15
MATOSHREE HEALTH CARE PVT LTD
$404.74
16
VINCCENT BIOTECH PVT LTD
$257.32
17
RUTVA MEDICARE
$241.86
18
PIRZE LIFECARE PVT LTD
$193.67
19
ZYPHARS PHARMACEUTICS PVT LTD
$155.03
20
BRUCK PHARMA PVT LTD
$154.59
21
M T MADON EXPORTS
$149.81
22
MDS ENTERPRISES
$138.42
23
WORLDPRIME EXPORT LLP
$81.59
24
3S CORP
$48.36
25
GOLDFIELD HEALTHCARE
$38.02
26
RUN MEDWAY
$30.60
27
BIOZENTA LIFESCIENCE PVT LTD
$27.12
28
DM WORLDWIDE TRADING
$24.75
29
MEDICOS LIFESCIENCES
$17.90
30
AL-ROYAL PHARMACEUTICAL PVT LTD
$14.66
Top 21 Africa importers
1
PHARMACIE POPULAIRE DU MALI · Mali
$23K
2
CENTRALE DACHATS DE MEDICAMENTS · Madagascar
$8K
3
DOMAKS INVESTMENT LTD · Nigeria
$2K
4
MOG LOGISTICS LLC · Egypt
$2K
5
PHARMACHEIME LTD · Malawi
$1K
6
PHILTA PHARMACY AND HEALTHCARE · Ghana
$432.31
7
NEW AFRICA SOFTWARE SOLUTION LTD · Ghana
$421.92
8
CENTRAIMED · Equatorial Guinea
$193.67
9
SALAMA PHARMACUTICALS LTD · Kenya
$144.81
10
AFRICURE PHARMACEUTICALS BURKINA SA · Burkina Faso
$128.66
11
FOR THE ORDER OF · Kenya
$48.36
12
CLYZ PHARMA SARL · Cameroon
$30.60
13
LUSAKA PHARMA CHEM SUPPLIES LTD · Zambia
$17.90
14
ROYAL PHARMA COMPANY · Egypt
$14.66
15
COPTIC ORTHODOX CHURCH / COPTIC · Zambia
$6.33
16
MOHAMED AHEMED MOHAMUD · Somalia
$5.00
17
AS PER INVOICE GHANA · Ghana
$2.79
18
DR (MS.) LEIA MONTEIRO, DIRECTOR · Mozambique
$2.45
19
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Egypt
$1.98
20
HANITRA RAZAOARIMANANA · Madagascar
$1.90
21
DR(MS)LEIA MONTEIRO DIRECTOR · Mozambique
$0.0000
Top 5 dosage forms
1
Injection
$42K
2
Tablet
$2K
3
Unknown
$1K
4
Other
$432.31
5
Powder for Injection
$0.0000
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $23K | $23K |
| Nov | 29 | $16K | $542.62 |
| Dec | 51 | $7K | $143.26 |
Shipment register · 81 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — PEACOCK MEDICINE COMPANY · 1 shipments · $23K | |||||||||||
| 1 | Oct 2025 | PHARMACIE POPULAIRE DU MALI | Mali | Injection | 15.0K | PCS | $1.50 | $23K | AHMEDABAD AIR | BAMAKO | AIR |
| SUPPLIER #2 — GETWELL PHARMA INDIA PVT LTD · 4 shipments · $8K | |||||||||||
| 2 | Nov 2025 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | Injection | 5.5K | NOS | $0.792 | $4K | DELHI AIR | ANTANANARIVO | AIR |
| 3 | Nov 2025 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | Injection | 5.5K | NOS | $0.735 | $4K | DELHI AIR | ANTANANARIVO | AIR |
| 4 | Nov 2025 | HANITRA RAZAOARIMANANA | Madagascar | Injection | 4 | NOS | $0.260 | $1.04 | DELHI AIR | ANTANANARIVO | AIR |
| 5 | Nov 2025 | HANITRA RAZAOARIMANANA | Madagascar | Injection | 4 | NOS | $0.216 | $0.865 | DELHI AIR | ANTANANARIVO | AIR |
| SUPPLIER #3 — ZUVIUS LIFESCIENCES PVT LTD · 6 shipments · $2K | |||||||||||
| 6 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 200 | NOS | $1.13 | $225.52 | DELHI AIR | LAGOS | AIR |
| 7 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 1.0K | NOS | $0.609 | $608.71 | DELHI AIR | LAGOS | AIR |
| 8 | Nov 2025 | UNKNOWN BUYER | Nigeria | Injection | 200 | NOS | $1.13 | $225.52 | DELHI AIR | LAGOS | AIR |
| 9 | Nov 2025 | UNKNOWN BUYER | Nigeria | Injection | 1.0K | NOS | $0.609 | $608.71 | DELHI AIR | LAGOS | AIR |
| 10 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 200 | NOS | $1.04 | $207.10 | DELHI AIR | LAGOS | AIR |
| 11 | Nov 2025 | DOMAKS INVESTMENT LTD | Nigeria | Injection | 1.0K | NOS | $0.559 | $558.98 | DELHI AIR | LAGOS | AIR |
| SUPPLIER #4 — S P AND COMPANY · 6 shipments · $2K | |||||||||||
| 12 | Dec 2025 | UNLISTED BUYER | Ghana | Injection | 100 | NOS | $1.33 | $132.66 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Ghana | Injection | 400 | NOS | $1.33 | $530.66 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | Ghana | Injection | 500 | NOS | $0.816 | $408.20 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Ghana | Injection | 100 | NOS | $1.33 | $132.66 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 16 | Dec 2025 | UNLISTED BUYER | Ghana | Injection | 400 | NOS | $1.33 | $530.66 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 17 | Dec 2025 | UNLISTED BUYER | Ghana | Injection | 500 | NOS | $0.816 | $408.20 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #5 — AARIA PHARMACEUTICALS PVT LTD · 1 shipments · $2K | |||||||||||
| 18 | Dec 2025 | MOG LOGISTICS LLC | Egypt | Tablet | 2.5K | NOS | $0.610 | $2K | NHAVA SHEVA SEA (JNPT) | Alexandra(Egypt) | SEA |
| SUPPLIER #6 — MATHI ASSOCIATES · 1 shipments · $1K | |||||||||||
| 19 | Nov 2025 | PHARMACHEIME LTD | Malawi | Injection | 1.0K | VLS | $1.32 | $1K | MUMBAI AIR (SAHAR) | LILONGWE | AIR |
| SUPPLIER #7 — KLV HEALTHCARE PVT LTD · 2 shipments · $1K | |||||||||||
| 20 | Dec 2025 | UNLISTED BUYER | Cameroon | Injection | 480 | NOS | $2.25 | $1K | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 21 | Dec 2025 | UNLISTED BUYER | Cameroon | Injection | 20 | NOS | $2.25 | $44.90 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #8 — CHAWLA MEDICOS · 1 shipments · $989.76 | |||||||||||
| 22 | Nov 2025 | UNLISTED BUYER | Ghana | 200 | PCS | $4.95 | $989.76 | DELHI AIR | ACCRA | AIR | |
| SUPPLIER #9 — SANSKRUTI PHARMA · 6 shipments · $739.43 | |||||||||||
| 23 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 150 | VLS | $1.19 | $178.14 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 24 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 150 | VLS | $1.14 | $171.28 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 25 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Injection | 150 | VLS | $1.14 | $171.28 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 26 | Nov 2025 | UNLISTED BUYER | Ghana | 30 | NOS | $1.50 | $44.90 | MUMBAI AIR (SAHAR) | ACCRA | AIR | |
| 27 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 150 | VLS | $1.14 | $171.26 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 28 | Dec 2025 | UNLISTED BUYER | Burkina Faso | Injection | 200 | VLS | $0.013 | $2.57 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #10 — MENAMED PHARMA PVT LTD · 2 shipments · $542.41 | |||||||||||
| 29 | Nov 2025 | UNLISTED BUYER | Burkina Faso | Injection | 150 | VLS | $1.81 | $271.21 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 30 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Injection | 150 | VLS | $1.81 | $271.21 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #11 — RMPL PHARMA LLP · 2 shipments · $477.08 | |||||||||||
| 31 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 310 | NOS | $0.477 | $147.89 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 32 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 690 | NOS | $0.477 | $329.18 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #12 — R.S. SURGIPHARM PVT LTD · 2 shipments · $471.27 | |||||||||||
| 33 | Dec 2025 | UNKNOWN BUYER | Kenya | Injection | 500 | VLS | $0.875 | $437.25 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 34 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 100 | NOS | $0.340 | $34.01 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #13 — LIFENEST PHARMA LLP · 1 shipments · $432.31 | |||||||||||
| 35 | Nov 2025 | PHILTA PHARMACY AND HEALTHCARE | Ghana | Other | 500 | NOS | $0.865 | $432.31 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #14 — WELLKIND PHARMACEUTICAL PVT LTD · 2 shipments · $421.92 | |||||||||||
| 36 | Nov 2025 | NEW AFRICA SOFTWARE SOLUTION LTD | Ghana | Injection | 500 | NOS | $0.669 | $334.67 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 37 | Nov 2025 | NEW AFRICA SOFTWARE SOLUTION LTD | Ghana | Injection | 178 | NOS | $0.490 | $87.26 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #15 — MATOSHREE HEALTH CARE PVT LTD · 1 shipments · $404.74 | |||||||||||
| 38 | Dec 2025 | UNKNOWN BUYER | Ethiopia | Injection | 500 | NOS | $0.809 | $404.74 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #16 — VINCCENT BIOTECH PVT LTD · 2 shipments · $257.32 | |||||||||||
| 39 | Nov 2025 | AFRICURE PHARMACEUTICALS BURKINA SA | Burkina Faso | Injection | 100 | NOS | $1.29 | $128.66 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| 40 | Nov 2025 | UNKNOWN BUYER | Burkina Faso | Injection | 100 | NOS | $1.29 | $128.66 | MUMBAI AIR (SAHAR) | OUAGADOUGOU | AIR |
| SUPPLIER #17 — RUTVA MEDICARE · 8 shipments · $241.86 | |||||||||||
| 41 | Dec 2025 | UNLISTED BUYER | Zimbabwe | 10 | PCS | $0.919 | $9.19 | AHMEDABAD AIR | HARARE | AIR | |
| 42 | Dec 2025 | UNLISTED BUYER | Zimbabwe | 30 | PCS | $0.204 | $6.12 | AHMEDABAD AIR | HARARE | AIR | |
| 43 | Dec 2025 | UNLISTED BUYER | Zimbabwe | 10 | PCS | $0.327 | $3.27 | AHMEDABAD AIR | HARARE | AIR | |
| 44 | Dec 2025 | UNLISTED BUYER | Ghana | 180 | PCS | $0.265 | $47.76 | AHMEDABAD AIR | ACCRA | AIR | |
| 45 | Dec 2025 | UNLISTED BUYER | Ghana | 500 | PCS | $0.265 | $132.67 | AHMEDABAD AIR | ACCRA | AIR | |
| 46 | Dec 2025 | UNLISTED BUYER | Ghana | 90 | PCS | $0.265 | $23.88 | AHMEDABAD AIR | ACCRA | AIR | |
| 47 | Dec 2025 | UNLISTED BUYER | Ghana | 60 | PCS | $0.265 | $15.92 | AHMEDABAD AIR | ACCRA | AIR | |
| 48 | Dec 2025 | UNLISTED BUYER | Ghana | 30 | PCS | $0.102 | $3.06 | AHMEDABAD AIR | ACCRA | AIR | |
| SUPPLIER #18 — PIRZE LIFECARE PVT LTD · 3 shipments · $193.67 | |||||||||||
| 49 | Dec 2025 | CENTRAIMED | Equatorial Guinea | 100 | NOS | $0.469 | $46.95 | AHMEDABAD AIR | MALABO | AIR | |
| 50 | Dec 2025 | CENTRAIMED | Equatorial Guinea | Injection | 80 | NOS | $1.47 | $117.37 | AHMEDABAD AIR | MALABO | AIR |
| 51 | Dec 2025 | CENTRAIMED | Equatorial Guinea | Injection | 20 | NOS | $1.47 | $29.35 | AHMEDABAD AIR | MALABO | AIR |
| SUPPLIER #19 — ZYPHARS PHARMACEUTICS PVT LTD · 1 shipments · $155.03 | |||||||||||
| 52 | Dec 2025 | UNKNOWN BUYER | Uganda | Tablet | 21 | NOS | $7.38 | $155.03 | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| SUPPLIER #20 — BRUCK PHARMA PVT LTD · 1 shipments · $154.59 | |||||||||||
| 53 | Dec 2025 | UNLISTED BUYER | Burundi | Injection | 100 | NOS | $1.55 | $154.59 | MUMBAI AIR (SAHAR) | BUJUMBURA | AIR |
| SUPPLIER #21 — M T MADON EXPORTS · 2 shipments · $149.81 | |||||||||||
| 54 | Dec 2025 | MOHAMED AHEMED MOHAMUD | Somalia | Injection | 500 | NOS | $0.010 | $5.00 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| 55 | Dec 2025 | SALAMA PHARMACUTICALS LTD | Kenya | Injection | 200 | NOS | $0.724 | $144.81 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #22 — MDS ENTERPRISES · 1 shipments · $138.42 | |||||||||||
| 56 | Nov 2025 | UNLISTED BUYER | Ghana | Injection | 200 | NOS | $0.692 | $138.42 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #23 — WORLDPRIME EXPORT LLP · 1 shipments · $81.59 | |||||||||||
| 57 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 140 | VLS | $0.583 | $81.59 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #24 — 3S CORP · 1 shipments · $48.36 | |||||||||||
| 58 | Nov 2025 | FOR THE ORDER OF | Kenya | Tablet | 150 | NOS | $0.322 | $48.36 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #25 — GOLDFIELD HEALTHCARE · 1 shipments · $38.02 | |||||||||||
| 59 | Dec 2025 | UNLISTED BUYER | Republic of the Congo | Injection | 50 | NOS | $0.760 | $38.02 | MUMBAI AIR (SAHAR) | POINTE NOIRE | AIR |
| SUPPLIER #26 — RUN MEDWAY · 1 shipments · $30.60 | |||||||||||
| 60 | Dec 2025 | CLYZ PHARMA SARL | Cameroon | Tablet | 100 | NOS | $0.306 | $30.60 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #27 — BIOZENTA LIFESCIENCE PVT LTD · 3 shipments · $27.12 | |||||||||||
| 61 | Dec 2025 | UNLISTED BUYER | Eswatini | Tablet | 150 | NOS | $0.114 | $17.08 | DELHI AIR | MATADI | AIR |
| 62 | Dec 2025 | UNLISTED BUYER | Eswatini | Injection | 150 | NOS | $0.019 | $2.78 | DELHI AIR | MATADI | AIR |
| 63 | Dec 2025 | UNLISTED BUYER | Eswatini | Injection | 350 | NOS | $0.021 | $7.26 | DELHI AIR | MATADI | AIR |
| SUPPLIER #28 — DM WORLDWIDE TRADING · 1 shipments · $24.75 | |||||||||||
| 64 | Dec 2025 | UNLISTED BUYER | Cote d'Ivoire | Injection | 10 | NOS | $2.47 | $24.75 | AHMEDABAD AIR | ABIDJAN | AIR |
| SUPPLIER #29 — MEDICOS LIFESCIENCES · 1 shipments · $17.90 | |||||||||||
| 65 | Dec 2025 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | Injection | 20 | NOS | $0.895 | $17.90 | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #30 — AL-ROYAL PHARMACEUTICAL PVT LTD · 1 shipments · $14.66 | |||||||||||
| 66 | Dec 2025 | ROYAL PHARMA COMPANY | Egypt | Injection | 2.0K | NOS | $0.0073 | $14.66 | DELHI AIR | ALEXANDRIA, EL NHOUZ | AIR |
| SUPPLIER #31 — SUBHRA PHARMA PRIAVATE LTD · 2 shipments · $9.47 | |||||||||||
| 67 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 3 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 68 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 3 | NOS | $3.16 | $9.47 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #32 — AZKA MEDTRADE AND SERVICES · 1 shipments · $7.40 | |||||||||||
| 69 | Dec 2025 | UNLISTED BUYER | Somalia | Injection | 1.0K | VLS | $0.0074 | $7.40 | MUMBAI AIR (SAHAR) | HARGEISA | SEA |
| SUPPLIER #33 — V. S. HEALTHCARE · 1 shipments · $6.33 | |||||||||||
| 70 | Nov 2025 | COPTIC ORTHODOX CHURCH / COPTIC | Zambia | Injection | 6 | NOS | $1.05 | $6.33 | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #34 — MELON GLOBALCARE · 2 shipments · $5.74 | |||||||||||
| 71 | Nov 2025 | UNLISTED BUYER | Cameroon | Injection | 10 | NOS | $0.448 | $4.48 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| 72 | Nov 2025 | UNLISTED BUYER | Cameroon | Tablet | 150 | NOS | $0.0084 | $1.27 | MUMBAI AIR (SAHAR) | DOUALA | AIR |
| SUPPLIER #35 — MBA PHARMACEUTICALS PVT LTD · 1 shipments · $3.59 | |||||||||||
| 73 | Dec 2025 | UNLISTED BUYER | Nigeria | Injection | 500 | VLS | $0.0072 | $3.59 | DELHI AIR | LAGOS | AIR |
| SUPPLIER #36 — VAMA HEALTH WORLD LLP · 2 shipments · $2.79 | |||||||||||
| 74 | Dec 2025 | AS PER INVOICE GHANA | Ghana | Injection | 70 | NOS | $0.019 | $1.36 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| 75 | Dec 2025 | AS PER INVOICE GHANA | Ghana | Injection | 70 | NOS | $0.021 | $1.44 | MUMBAI AIR (SAHAR) | ACCRA | AIR |
| SUPPLIER #37 — S. HIMATLAL HEALTHCARE LLP · 2 shipments · $2.57 | |||||||||||
| 76 | Dec 2025 | UNLISTED BUYER | Ethiopia | Injection | 480 | NOS | $0.0051 | $2.47 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| 77 | Dec 2025 | UNLISTED BUYER | Ethiopia | Injection | 20 | NOS | $0.0051 | $0.103 | MUMBAI AIR (SAHAR) | ADDIS ABABA | AIR |
| SUPPLIER #38 — HSCC (INDIA) LTD · 2 shipments · $2.45 | |||||||||||
| 78 | Dec 2025 | DR (MS.) LEIA MONTEIRO, DIRECTOR | Mozambique | Tablet | 12.0K | NOS | $0.0002 | $2.45 | MUNDRA SEA | Maputo | SEA |
| 79 | Dec 2025 | DR(MS)LEIA MONTEIRO DIRECTOR | Mozambique | Powder for Injection | 8.2K | NOS | $0.0000 | $0.0000 | DELHI AIR | MAPUTO | AIR |
| SUPPLIER #39 — J.A. UNITED EXPORTS PVT LTD · 2 shipments · $1.98 | |||||||||||
| 80 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | Injection | 353 | VLS | $0.0039 | $1.37 | MUMBAI AIR (SAHAR) | CAIRO | AIR |
| 81 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Egypt | Injection | 100 | VLS | $0.0062 | $0.615 | MUMBAI AIR (SAHAR) | CAIRO | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
16 countries · 80 shipments · $50K · 29 Indian suppliers · 25 buyers
SHIPMENTS
80
USD
$50K
COUNTRIES
16
SUPPLIERS
29
BUYERS
25
HHI
2,065
moderate
Top 16 destination countries in Asia
1
Nepal (34.8%)
$17K
2
Afghanistan (30.5%)
$15K
3
Philippines (12.9%)
$6K
4
Laos (5.5%)
$3K
5
United Arab Emirates (4.0%)
$2K
6
Bhutan (4.0%)
$2K
7
Lebanon (4.0%)
$2K
8
Singapore (1.6%)
$814.26
9
Turkey (1.0%)
$475.73
10
Cambodia (0.7%)
$364.32
11
Yemen (0.4%)
$177.59
12
Mongolia (0.2%)
$106.38
13
Sri Lanka (0.2%)
$94.46
14
China (0.2%)
$92.08
15
Maldives (0.0%)
$18.99
16
Iraq (0.0%)
$2.73
Top 29 Indian suppliers into Asia
1
INDOCO REMEDIES LTD
$16K
2
KWALITY PHARMACEUTICALS LTD
$14K
3
GETWELL PHARMA INDIA PVT LTD
$6K
4
ARYSON HEALTHCARE PVT LTD
$3K
5
SALVAVIDAS PHARMACEUTICAL PVT LTD
$2K
6
TRIKAYA GLOBAL
$2K
7
MALLESHWAR SPECIALITIES
$1K
8
KERK
$965.88
9
REGALIA LIFE SCIENCE PVT LTD
$760.08
10
DOSSMEGT PHARMACEUTICALS PVT LTD
$519.11
11
S. HIMATLAL HEALTHCARE LLP
$475.63
12
DROPS PHARMA PVT LTD
$398.36
13
UNITED BIOTECH PVT LTD
$393.96
14
LEOWIN HEALTHCARE LLP
$375.85
15
VANDAN HEALTHCARE
$364.32
16
MEDEX PHARMACEUTICALS
$310.47
17
BAKER & DAVIS PVT LTD
$297.51
18
J.A. UNITED EXPORTS PVT LTD
$177.59
19
PHARMA CHOICE LLP
$140.89
20
JMB PHARMACEUTICALS PVT LTD
$92.08
21
RMPL PHARMA LLP
$73.75
22
PLEASANT EXPORTS
$69.43
23
MEDMATRIX ASSOCIATES
$61.22
24
MEDMALL PHARMACY PVT LTD
$25.03
25
NU HOSPITALS PVT LTD
$18.99
26
MDS ENTERPRISES
$3.02
27
DISTINCT IMPEX PVT LTD
$2.73
28
ZYPHARS PHARMACEUTICS PVT LTD
$0.146
29
ZIL PHARMA
$0.118
Top 23 Asia importers
1
BIRGANJ MEDI SA · Nepal
$16K
2
TRUST ANESTHETIC LTD · Afghanistan
$14K
3
AMBICA INTERNATIONAL CORP · Philippines
$5K
4
IC PHARMA LAO CO LTD · Laos
$3K
5
RENATO C LOZADA · Philippines
$1K
6
VISION CARE INTERNATIONAL PVT LTD · Nepal
$1K
7
MUBARAK HASHIMI LTD · Afghanistan
$965.88
8
AUTOMOBILE TRANSPORTATION SERVICES · Lebanon
$952.88
9
TO THE PURCHASE MANAGER IMPORT DEPA · United Arab Emirates
$760.08
10
NIKHIL PHARMA PVT LTD · Nepal
$393.96
11
RAPATI ENTERPRISES · Singapore
$297.51
12
NOVO GENERAL TRADING FZE · United Arab Emirates
$259.56
13
MEDIMART DRUG STORE · United Arab Emirates
$211.06
14
AL-NOOR FOR DRUGS & MEDICAL APPLIAN · Yemen
$177.59
15
BEST INTERNATIONAL FZE · United Arab Emirates
$155.23
16
RADEEP SERVICES · Singapore
$140.89
17
TSOMBO LLC · Mongolia
$106.38
18
DALIAN CHAOHONGSUPPLY CHAIN MANAGEM · China
$92.08
19
THE ESSES PHARMACY (PVT) LTD · Sri Lanka
$69.43
20
GULF IMPEX FZC · Afghanistan
$61.22
21
PRISM INTERNATIONAL LLC · Sri Lanka
$25.03
22
INDIRA GANDHI MEMOROAL HOSPITAL · Maldives
$18.99
23
TO,THE ORDER OF · United Arab Emirates
$0.146
Top 4 dosage forms
1
Tablet
$19K
2
Injection
$13K
3
Suspension
$12K
4
Unknown
$5K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 9 | $2K | $256.36 |
| Nov | 29 | $44K | $2K |
| Dec | 42 | $3K | $72.78 |
Shipment register · 80 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — INDOCO REMEDIES LTD · 4 shipments · $16K | |||||||||||
| 1 | Nov 2025 | BIRGANJ MEDI SA | Nepal | Tablet | 7.2K | NOS | $0.320 | $2K | RAXAUL | Birgunj | ROAD |
| 2 | Nov 2025 | BIRGANJ MEDI SA | Nepal | Suspension | 14.6K | NOS | $0.458 | $7K | RAXAUL | Birgunj | ROAD |
| 3 | Nov 2025 | BIRGANJ MEDI SA | Nepal | Suspension | 11.4K | NOS | $0.458 | $5K | RAXAUL | Birgunj | ROAD |
| 4 | Nov 2025 | BIRGANJ MEDI SA | Nepal | Tablet | 4.8K | NOS | $0.320 | $2K | RAXAUL | Birgunj | ROAD |
| SUPPLIER #2 — KWALITY PHARMACEUTICALS LTD · 3 shipments · $14K | |||||||||||
| 5 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Injection | 3.0K | NOS | $0.611 | $2K | DELHI AIR | KABUL | AIR |
| 6 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Tablet | 500.0K | NOS | $0.021 | $11K | DELHI AIR | KABUL | AIR |
| 7 | Nov 2025 | TRUST ANESTHETIC LTD | Afghanistan | Injection | 3.0K | NOS | $0.548 | $2K | DELHI AIR | KABUL | AIR |
| SUPPLIER #3 — GETWELL PHARMA INDIA PVT LTD · 5 shipments · $6K | |||||||||||
| 8 | Nov 2025 | AMBICA INTERNATIONAL CORP | Philippines | 6.0K | NOS | $0.876 | $5K | DELHI AIR | MANILA | AIR | |
| 9 | Nov 2025 | VISION CARE INTERNATIONAL PVT LTD | Nepal | Injection | 1.0K | NOS | $0.218 | $218.42 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 10 | Nov 2025 | VISION CARE INTERNATIONAL PVT LTD | Nepal | Injection | 1.0K | NOS | $0.546 | $546.04 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 11 | Nov 2025 | VISION CARE INTERNATIONAL PVT LTD | Nepal | Injection | 1.0K | NOS | $0.328 | $327.62 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 12 | Nov 2025 | TSOMBO LLC | Mongolia | Injection | 200 | NOS | $0.532 | $106.38 | DELHI AIR | ULAANBAATAR | AIR |
| SUPPLIER #4 — ARYSON HEALTHCARE PVT LTD · 1 shipments · $3K | |||||||||||
| 13 | Nov 2025 | IC PHARMA LAO CO LTD | Laos | Injection | 400 | VLS | $6.76 | $3K | MUMBAI AIR (SAHAR) | VIENTIANE | AIR |
| SUPPLIER #5 — SALVAVIDAS PHARMACEUTICAL PVT LTD · 1 shipments · $2K | |||||||||||
| 14 | Nov 2025 | UNLISTED BUYER | Bhutan | Tablet | 1.4K | NOS | $1.42 | $2K | JAIGAON LCS | Phuntsholing | ROAD |
| SUPPLIER #6 — TRIKAYA GLOBAL · 2 shipments · $2K | |||||||||||
| 15 | Nov 2025 | AUTOMOBILE TRANSPORTATION SERVICES | Lebanon | Injection | 1.0K | VLS | $0.953 | $952.88 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 16 | Nov 2025 | UNKNOWN BUYER | Lebanon | Injection | 1.0K | VLS | $0.953 | $952.88 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| SUPPLIER #7 — MALLESHWAR SPECIALITIES · 3 shipments · $1K | |||||||||||
| 17 | Oct 2025 | RENATO C LOZADA | Philippines | Tablet | 1.0K | NOS | $0.376 | $375.85 | BANGALORE AIR | MANILA | AIR |
| 18 | Oct 2025 | RENATO C LOZADA | Philippines | Tablet | 1.0K | NOS | $0.376 | $375.86 | BANGALORE AIR | MANILA | AIR |
| 19 | Oct 2025 | RENATO C LOZADA | Philippines | Tablet | 1.0K | NOS | $0.376 | $375.86 | BANGALORE AIR | MANILA | AIR |
| SUPPLIER #8 — KERK · 2 shipments · $965.88 | |||||||||||
| 20 | Dec 2025 | MUBARAK HASHIMI LTD | Afghanistan | Tablet | 1.0K | NOS | $0.278 | $278.44 | TUGHLAKABAD ICD | Kandahar | ICD |
| 21 | Dec 2025 | MUBARAK HASHIMI LTD | Afghanistan | Tablet | 2.0K | NOS | $0.344 | $687.44 | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #9 — REGALIA LIFE SCIENCE PVT LTD · 14 shipments · $760.08 | |||||||||||
| 22 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 20 | NOS | $15.41 | $308.19 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 23 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 20 | NOS | $0.204 | $4.08 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 24 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 20 | NOS | $5.09 | $101.85 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 25 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 30 | NOS | $5.10 | $153.08 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 26 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 24 | NOS | $1.09 | $26.21 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 27 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 6 | NOS | $1.09 | $6.55 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 28 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 20 | NOS | $1.09 | $21.84 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 29 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 10 | NOS | $0.745 | $7.45 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 30 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 10 | NOS | $0.745 | $7.45 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 31 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 5 | NOS | $0.102 | $0.510 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 32 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 50 | NOS | $0.140 | $6.99 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 33 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 2 | NOS | $0.612 | $1.22 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 34 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 11 | NOS | $2.28 | $25.11 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 35 | Dec 2025 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | Injection | 7 | NOS | $12.79 | $89.55 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #10 — DOSSMEGT PHARMACEUTICALS PVT LTD · 2 shipments · $519.11 | |||||||||||
| 36 | Nov 2025 | NOVO GENERAL TRADING FZE | United Arab Emirates | Injection | 500 | NOS | $0.519 | $259.56 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 37 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 500 | NOS | $0.519 | $259.56 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #11 — S. HIMATLAL HEALTHCARE LLP · 1 shipments · $475.63 | |||||||||||
| 38 | Oct 2025 | UNLISTED BUYER | Turkey | Injection | 1.0K | VLS | $0.476 | $475.63 | NHAVA SHEVA SEA (JNPT) | Mersin | SEA |
| SUPPLIER #12 — DROPS PHARMA PVT LTD · 7 shipments · $398.36 | |||||||||||
| 39 | Oct 2025 | MEDIMART DRUG STORE | United Arab Emirates | Tablet | 20 | NOS | $4.31 | $86.19 | COCHIN SEA | DUBAI | AIR |
| 40 | Oct 2025 | MEDIMART DRUG STORE | United Arab Emirates | Injection | 150 | NOS | $0.832 | $124.87 | COCHIN SEA | DUBAI | AIR |
| 41 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 30 | NOS | $0.988 | $29.64 | COCHIN AIR | DUBAI | AIR |
| 42 | Nov 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 50 | NOS | $0.988 | $49.41 | COCHIN AIR | DUBAI | AIR |
| 43 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 50 | NOS | $1.01 | $50.51 | COCHIN AIR | DUBAI | AIR |
| 44 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 75 | NOS | $0.657 | $49.25 | COCHIN AIR | DUBAI | AIR |
| 45 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 2 | NOS | $4.24 | $8.48 | COCHIN AIR | DUBAI | AIR |
| SUPPLIER #13 — UNITED BIOTECH PVT LTD · 3 shipments · $393.96 | |||||||||||
| 46 | Nov 2025 | NIKHIL PHARMA PVT LTD | Nepal | 300 | PCS | $0.800 | $240.11 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR | |
| 47 | Dec 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 200 | PCS | $0.457 | $91.37 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| 48 | Dec 2025 | NIKHIL PHARMA PVT LTD | Nepal | Injection | 300 | PCS | $0.208 | $62.48 | DELHI AIR | KATHMANDU - TRIBHUVA | AIR |
| SUPPLIER #14 — LEOWIN HEALTHCARE LLP · 1 shipments · $375.85 | |||||||||||
| 49 | Oct 2025 | UNLISTED BUYER | Singapore | Injection | 300 | NOS | $1.25 | $375.85 | AHMEDABAD AIR | SINGAPORE | AIR |
| SUPPLIER #15 — VANDAN HEALTHCARE · 1 shipments · $364.32 | |||||||||||
| 50 | Dec 2025 | UNLISTED BUYER | Cambodia | Injection | 210 | NOS | $1.73 | $364.32 | AHMEDABAD AIR | PHNOM PENH - POCHENT | AIR |
| SUPPLIER #16 — MEDEX PHARMACEUTICALS · 6 shipments · $310.47 | |||||||||||
| 51 | Nov 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 50 | NOS | $0.908 | $45.42 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 52 | Nov 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 7 | NOS | $1.10 | $7.69 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 53 | Nov 2025 | BEST INTERNATIONAL FZE | United Arab Emirates | Injection | 93 | NOS | $1.10 | $102.13 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 54 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 50 | NOS | $0.908 | $45.42 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 55 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 7 | NOS | $1.10 | $7.69 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 56 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Injection | 93 | NOS | $1.10 | $102.13 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #17 — BAKER & DAVIS PVT LTD · 1 shipments · $297.51 | |||||||||||
| 57 | Dec 2025 | RAPATI ENTERPRISES | Singapore | Tablet | 850 | NOS | $0.350 | $297.51 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #18 — J.A. UNITED EXPORTS PVT LTD · 2 shipments · $177.59 | |||||||||||
| 58 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 353 | VLS | $0.347 | $122.48 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| 59 | Dec 2025 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | Injection | 100 | VLS | $0.551 | $55.10 | MUMBAI AIR (SAHAR) | ADEN | AIR |
| SUPPLIER #19 — PHARMA CHOICE LLP · 2 shipments · $140.89 | |||||||||||
| 60 | Nov 2025 | RADEEP SERVICES | Singapore | Tablet | 200 | NOS | $0.317 | $63.35 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 61 | Nov 2025 | RADEEP SERVICES | Singapore | Tablet | 150 | NOS | $0.517 | $77.55 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #20 — JMB PHARMACEUTICALS PVT LTD · 5 shipments · $92.08 | |||||||||||
| 62 | Oct 2025 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | Injection | 100 | NOS | $0.921 | $92.08 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 63 | Dec 2025 | UNLISTED BUYER | China | Injection | 100 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 64 | Dec 2025 | UNLISTED BUYER | China | Injection | 4.0K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 65 | Dec 2025 | UNLISTED BUYER | China | Injection | 100 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| 66 | Dec 2025 | UNLISTED BUYER | China | Injection | 4.0K | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Dalian | SEA |
| SUPPLIER #21 — RMPL PHARMA LLP · 2 shipments · $73.75 | |||||||||||
| 67 | Dec 2025 | UNLISTED BUYER | Lebanon | Tablet | 20 | NOS | $3.68 | $73.65 | MUMBAI AIR (SAHAR) | BEIRUT | AIR |
| 68 | Dec 2025 | UNLISTED BUYER | Turkey | Tablet | 100 | NOS | $0.0010 | $0.101 | MUMBAI AIR (SAHAR) | ADANA | AIR |
| SUPPLIER #22 — PLEASANT EXPORTS · 1 shipments · $69.43 | |||||||||||
| 69 | Dec 2025 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | Tablet | 200 | NOS | $0.347 | $69.43 | CHENNAI AIR | COLOMBO | AIR |
| SUPPLIER #23 — MEDMATRIX ASSOCIATES · 1 shipments · $61.22 | |||||||||||
| 70 | Dec 2025 | GULF IMPEX FZC | Afghanistan | Tablet | 200 | NOS | $0.306 | $61.22 | DADRI ICD | KABUL | ICD |
| SUPPLIER #24 — MEDMALL PHARMACY PVT LTD · 1 shipments · $25.03 | |||||||||||
| 71 | Oct 2025 | PRISM INTERNATIONAL LLC | Sri Lanka | Tablet | 5 | NOS | $5.01 | $25.03 | CHENNAI AIR | COLOMBO | AIR |
| SUPPLIER #25 — NU HOSPITALS PVT LTD · 1 shipments · $18.99 | |||||||||||
| 72 | Dec 2025 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | Injection | 6 | NOS | $3.17 | $18.99 | BANGALORE AIR | MALE | AIR |
| SUPPLIER #26 — MDS ENTERPRISES · 4 shipments · $3.02 | |||||||||||
| 73 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 4 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 74 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 496 | NOS | $0.0000 | $0.0000 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 75 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 4 | NOS | $0.0060 | $0.024 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| 76 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Injection | 496 | NOS | $0.0060 | $2.99 | MUMBAI AIR (SAHAR) | SHARJAH | AIR |
| SUPPLIER #27 — DISTINCT IMPEX PVT LTD · 2 shipments · $2.73 | |||||||||||
| 77 | Dec 2025 | UNLISTED BUYER | Iraq | Injection | 200 | NOS | $0.0068 | $1.37 | MUMBAI AIR (SAHAR) | Erbil Inter airport | AIR |
| 78 | Dec 2025 | UNLISTED BUYER | Iraq | Injection | 200 | NOS | $0.0068 | $1.37 | MUMBAI AIR (SAHAR) | Erbil Inter airport | AIR |
| SUPPLIER #28 — ZYPHARS PHARMACEUTICS PVT LTD · 1 shipments · $0.146 | |||||||||||
| 79 | Dec 2025 | TO,THE ORDER OF | United Arab Emirates | Tablet | 3 | NOS | $0.049 | $0.146 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #29 — ZIL PHARMA · 1 shipments · $0.118 | |||||||||||
| 80 | Dec 2025 | UNLISTED BUYER | United Arab Emirates | Tablet | 300 | NOS | $0.0004 | $0.118 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
2 countries · 4 shipments · $16K · 2 Indian suppliers · 2 buyers
SHIPMENTS
4
USD
$16K
COUNTRIES
2
SUPPLIERS
2
BUYERS
2
HHI
9,962
concentrated
Top 2 destination countries in Europe
1
Moldova (99.8%)
$16K
2
Italy (0.2%)
$30.51
Top 2 Indian suppliers into Europe
1
KWALITY PHARMACEUTICALS LTD
$16K
2
ZYPHARS PHARMACEUTICS PVT LTD
$30.51
Top 1 Europe importers
1
DITA ESTFARM LLC · Moldova
$8K
Top 2 dosage forms
1
Injection
$16K
2
Tablet
$30.51
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 2 | $16K | $8K |
| Dec | 2 | $155.80 | $77.90 |
Shipment register · 4 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — KWALITY PHARMACEUTICALS LTD · 3 shipments · $16K | |||||||||||
| 1 | Nov 2025 | DITA ESTFARM LLC | Moldova | Injection | 14.7K | NOS | $0.539 | $8K | DELHI AIR | CHISINAU | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | Moldova | Injection | 14.7K | NOS | $0.539 | $8K | DELHI AIR | CHISINAU | AIR |
| 3 | Dec 2025 | DITA ESTFARM LLC | Moldova | Injection | 20.0K | NOS | $0.0063 | $125.28 | DELHI AIR | CHISINAU | SEA |
| SUPPLIER #2 — ZYPHARS PHARMACEUTICS PVT LTD · 1 shipments · $30.51 | |||||||||||
| 4 | Dec 2025 | UNKNOWN BUYER | Italy | Tablet | 5 | NOS | $6.10 | $30.51 | MUMBAI AIR (SAHAR) | BOLOGNA | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
14 countries · 54 shipments · $2.84M · 22 Indian suppliers · 17 buyers
SHIPMENTS
54
USD
$2.84M
COUNTRIES
14
SUPPLIERS
22
BUYERS
17
HHI
8,804
concentrated
Top 14 destination countries in Americas
1
United States (97.5%)
$2.77M
2
Mexico (1.1%)
$30K
3
Venezuela (1.0%)
$27K
4
Ecuador (0.2%)
$7K
5
Nicaragua (0.2%)
$5K
6
Jamaica (0.0%)
$1K
7
Barbados (0.0%)
$383.88
8
Haiti (0.0%)
$184.30
9
Saint Lucia (0.0%)
$133.97
10
Trinidad and Tobago (0.0%)
$71.08
11
Dominica (0.0%)
$52.12
12
Cayman Islands (0.0%)
$22.99
13
British Virgin Islands (0.0%)
$17.93
14
Dominican Republic (0.0%)
$8.54
Top 22 Indian suppliers into Americas
1
EUGIA PHARMA SPECIALITIES LTD
$2.66M
2
ALEMBIC PHARMACEUTICALS LTD
$106K
3
AMRS HEALTHCARE PVT LTD
$27K
4
KWALITY PHARMACEUTICALS LTD
$21K
5
MYGENIC HEALTHCARE PVT LTD
$7K
6
SUBHRA PHARMA PRIAVATE LTD
$7K
7
UNITED BIOTECH PVT LTD
$5K
8
VAMA HEALTH WORLD LLP
$2K
9
GETWELL PHARMA INDIA PVT LTD
$1K
10
MEDINEX HEALTHCARE
$610.35
11
ANINS HEALTHCARE PVT LTD
$382.47
12
ATLAS ENTERPRISES
$368.14
13
DOSSMEGT PHARMACEUTICALS PVT LTD
$184.30
14
SARA TRADING CORP
$124.30
15
TIGER REMEDIES
$65.89
16
TOVEC PHARMA PVT LTD
$52.12
17
AKSHAR PHARMA
$39.59
18
PARKSLEY GLOBAL PVT LTD
$27.60
19
NARAYANA HRUDAYALAYA LTD
$22.99
20
FLORENCIA HEALTHCARE
$8.54
21
BRINTON PHARMACEUTICALS LTD
$1.41
22
DISTINCT IMPEX PVT LTD
$0.592
Top 15 Americas importers
1
EUGIA US LLC · United States
$2.66M
2
J. KNIPPER & COMPANY · United States
$106K
3
ACCESORIOS SUMINISTROS Y EQUIPO MED · Mexico
$21K
4
CORPORACION FARMACEUTICA DE C.A.S.A · Nicaragua
$5K
5
AS PER INVOICE MEXICO · Mexico
$2K
6
RECHARGED DISTRIBUTORS LTD · Jamaica
$1K
7
GP AVIS AGENCIES INC · Barbados
$382.47
8
DISTRIBUIDORA MEDICA PAREDES S.DE · Mexico
$359.59
9
HOPITAL CARAMED CLINIQUE DU CANCE · Haiti
$184.30
10
CARIMED TRADING · Saint Lucia
$53.18
11
A LA ORDEN DE FACTURA LEVANTADA A · Saint Lucia
$27.60
12
HEALTH CITY CAYMAN ISLANDS (HCCI) · Cayman Islands
$22.99
13
VANTERPOOL ENTERPRISES LTD · British Virgin Islands
$17.93
14
DISTRIBUIDORA MEDICA PAREDES S.DE R · Mexico
$8.54
15
SUNCREST INTERNATIONAL LTD · Trinidad and Tobago
$5.19
Top 6 dosage forms
1
Injection
$2.72M
2
Capsule
$106K
3
Unknown
$7K
4
Tablet
$618.78
5
Vial
$571.12
6
Powder
$391.01
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 7 | $2.66M | $380K |
| Nov | 19 | $147K | $8K |
| Dec | 28 | $30K | $1K |
Shipment register · 54 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — EUGIA PHARMA SPECIALITIES LTD · 4 shipments · $2.66M | |||||||||||
| 1 | Oct 2025 | EUGIA US LLC | United States | Injection | 3.3K | NOS | $158.35 | $530K | HYDERABAD AIR | ATLANTA, HARTSFIELD | AIR |
| 2 | Oct 2025 | EUGIA US LLC | United States | Injection | 8.3K | NOS | $66.49 | $552K | HYDERABAD AIR | ATLANTA, HARTSFIELD | AIR |
| 3 | Oct 2025 | EUGIA US LLC | United States | Injection | 8.1K | NOS | $66.89 | $544K | HYDERABAD ICD | SAVANNAH | ICD |
| 4 | Oct 2025 | EUGIA US LLC | United States | Injection | 6.5K | NOS | $158.83 | $1.04M | HYDERABAD ICD | SAVANNAH | ICD |
| SUPPLIER #2 — ALEMBIC PHARMACEUTICALS LTD · 2 shipments · $106K | |||||||||||
| 5 | Nov 2025 | J. KNIPPER & COMPANY | United States | Capsule | 102.0K | NOS | $0.188 | $19K | MUNDRA SEA | New York | SEA |
| 6 | Nov 2025 | J. KNIPPER & COMPANY | United States | Capsule | 289.2K | NOS | $0.299 | $87K | MUNDRA SEA | New York | SEA |
| SUPPLIER #3 — AMRS HEALTHCARE PVT LTD · 2 shipments · $27K | |||||||||||
| 7 | Nov 2025 | UNLISTED BUYER | Venezuela | Injection | 8.5K | NOS | $0.868 | $7K | DELHI AIR | CARACAS | AIR |
| 8 | Nov 2025 | UNLISTED BUYER | Venezuela | Injection | 23.2K | NOS | $0.868 | $20K | DELHI AIR | CARACAS | AIR |
| SUPPLIER #4 — KWALITY PHARMACEUTICALS LTD · 1 shipments · $21K | |||||||||||
| 9 | Dec 2025 | ACCESORIOS SUMINISTROS Y EQUIPO MED | Mexico | Injection | 30.0K | NOS | $0.692 | $21K | DELHI AIR | MEXICO CITY | AIR |
| SUPPLIER #5 — MYGENIC HEALTHCARE PVT LTD · 7 shipments · $7K | |||||||||||
| 10 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 50 | NOS | $0.057 | $2.84 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 11 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 1.5K | NOS | $0.817 | $1K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 12 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 1.5K | NOS | $0.715 | $1K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 13 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 1.5K | NOS | $0.817 | $1K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 14 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 1.5K | NOS | $0.715 | $1K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 15 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 1.5K | NOS | $0.816 | $1K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 16 | Dec 2025 | UNLISTED BUYER | Mexico | Injection | 1.5K | NOS | $0.714 | $1K | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #6 — SUBHRA PHARMA PRIAVATE LTD · 2 shipments · $7K | |||||||||||
| 17 | Nov 2025 | UNLISTED BUYER | Ecuador | 7.3K | NOS | $0.689 | $5K | MUMBAI AIR (SAHAR) | QUITO | AIR | |
| 18 | Nov 2025 | UNLISTED BUYER | Ecuador | 2.7K | NOS | $0.689 | $2K | MUMBAI AIR (SAHAR) | QUITO | AIR | |
| SUPPLIER #7 — UNITED BIOTECH PVT LTD · 2 shipments · $5K | |||||||||||
| 19 | Nov 2025 | CORPORACION FARMACEUTICA DE C.A.S.A | Nicaragua | Injection | 6.4K | VLS | $0.497 | $3K | DELHI AIR | MANAGUA | AIR |
| 20 | Nov 2025 | CORPORACION FARMACEUTICA DE C.A.S.A | Nicaragua | Injection | 1.9K | VLS | $0.994 | $2K | DELHI AIR | MANAGUA | AIR |
| SUPPLIER #8 — VAMA HEALTH WORLD LLP · 7 shipments · $2K | |||||||||||
| 21 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Injection | 44 | NOS | $0.714 | $31.43 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 22 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Injection | 336 | NOS | $0.714 | $240.02 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 23 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Injection | 50 | NOS | $0.561 | $28.06 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 24 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Injection | 490 | NOS | $0.561 | $275.03 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 25 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Tablet | 100 | NOS | $3.78 | $377.59 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 26 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Injection | 465 | NOS | $0.714 | $331.99 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 27 | Dec 2025 | AS PER INVOICE MEXICO | Mexico | Injection | 410 | NOS | $0.561 | $230.00 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #9 — GETWELL PHARMA INDIA PVT LTD · 4 shipments · $1K | |||||||||||
| 28 | Nov 2025 | SUNCREST INTERNATIONAL LTD | Trinidad and Tobago | 2 | NOS | $1.50 | $2.99 | DELHI AIR | PORT OF SPAIN, PIARC | AIR | |
| 29 | Nov 2025 | SUNCREST INTERNATIONAL LTD | Trinidad and Tobago | 2 | NOS | $1.10 | $2.20 | DELHI AIR | PORT OF SPAIN, PIARC | AIR | |
| 30 | Nov 2025 | RECHARGED DISTRIBUTORS LTD | Jamaica | Injection | 500 | NOS | $1.31 | $653.69 | DELHI AIR | KINGSTON | AIR |
| 31 | Nov 2025 | RECHARGED DISTRIBUTORS LTD | Jamaica | Injection | 500 | NOS | $1.13 | $566.76 | DELHI AIR | KINGSTON | AIR |
| SUPPLIER #10 — MEDINEX HEALTHCARE · 3 shipments · $610.35 | |||||||||||
| 32 | Dec 2025 | UNLISTED BUYER | Mexico | Tablet | 10 | NOS | $3.92 | $39.23 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 33 | Dec 2025 | UNLISTED BUYER | Mexico | Vial | 400 | VLS | $0.816 | $326.35 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 34 | Dec 2025 | UNLISTED BUYER | Mexico | Vial | 400 | VLS | $0.612 | $244.77 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #11 — ANINS HEALTHCARE PVT LTD · 1 shipments · $382.47 | |||||||||||
| 35 | Dec 2025 | GP AVIS AGENCIES INC | Barbados | Powder | 300 | NOS | $1.27 | $382.47 | DELHI AIR | BRIDGETOWN | AIR |
| SUPPLIER #12 — ATLAS ENTERPRISES · 3 shipments · $368.14 | |||||||||||
| 36 | Nov 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE | Mexico | 500 | NOS | $0.719 | $359.59 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR | |
| 37 | Dec 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | Powder | 250 | NOS | $0.011 | $2.85 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| 38 | Dec 2025 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | Powder | 500 | NOS | $0.011 | $5.69 | MUMBAI AIR (SAHAR) | MEXICO CITY | AIR |
| SUPPLIER #13 — DOSSMEGT PHARMACEUTICALS PVT LTD · 1 shipments · $184.30 | |||||||||||
| 39 | Nov 2025 | HOPITAL CARAMED CLINIQUE DU CANCE | Haiti | Injection | 200 | NOS | $0.921 | $184.30 | MUMBAI AIR (SAHAR) | PORT AU PRINCE | AIR |
| SUPPLIER #14 — SARA TRADING CORP · 3 shipments · $124.30 | |||||||||||
| 40 | Nov 2025 | CARIMED TRADING | Saint Lucia | Tablet | 10 | NOS | $5.32 | $53.18 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 41 | Nov 2025 | UNKNOWN BUYER | Saint Lucia | Tablet | 10 | NOS | $5.32 | $53.18 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 42 | Dec 2025 | VANTERPOOL ENTERPRISES LTD | British Virgin Islands | Tablet | 16 | NOS | $1.12 | $17.93 | MUMBAI AIR (SAHAR) | TORTOLA | AIR |
| SUPPLIER #15 — TIGER REMEDIES · 1 shipments · $65.89 | |||||||||||
| 43 | Nov 2025 | UNLISTED BUYER | Trinidad and Tobago | Tablet | 60 | NOS | $1.10 | $65.89 | MUMBAI AIR (SAHAR) | PORT OF SPAIN, PIARC | AIR |
| SUPPLIER #16 — TOVEC PHARMA PVT LTD · 1 shipments · $52.12 | |||||||||||
| 44 | Dec 2025 | UNLISTED BUYER | Dominica | Injection | 50 | PCS | $1.04 | $52.12 | MUMBAI AIR (SAHAR) | DOMINICA | AIR |
| SUPPLIER #17 — AKSHAR PHARMA · 2 shipments · $39.59 | |||||||||||
| 45 | Nov 2025 | UNLISTED BUYER | Jamaica | Injection | 15 | PCS | $1.32 | $19.80 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 46 | Nov 2025 | UNKNOWN BUYER | Jamaica | Injection | 15 | PCS | $1.32 | $19.80 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| SUPPLIER #18 — PARKSLEY GLOBAL PVT LTD · 1 shipments · $27.60 | |||||||||||
| 47 | Dec 2025 | A LA ORDEN DE FACTURA LEVANTADA A | Saint Lucia | Injection | 30 | NOS | $0.920 | $27.60 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| SUPPLIER #19 — NARAYANA HRUDAYALAYA LTD · 3 shipments · $22.99 | |||||||||||
| 48 | Oct 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Injection | 2 | NOS | $1.39 | $2.77 | BANGALORE AIR | GEORGETOWN | AIR |
| 49 | Oct 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Injection | 5 | NOS | $3.37 | $16.84 | BANGALORE AIR | GEORGETOWN | AIR |
| 50 | Oct 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Injection | 1 | NOS | $3.37 | $3.37 | BANGALORE AIR | GEORGETOWN | AIR |
| SUPPLIER #20 — FLORENCIA HEALTHCARE · 1 shipments · $8.54 | |||||||||||
| 51 | Dec 2025 | UNLISTED BUYER | Dominican Republic | Tablet | 600 | VLS | $0.014 | $8.54 | DELHI AIR | SANTO DOMINGO | SEA |
| SUPPLIER #21 — BRINTON PHARMACEUTICALS LTD · 1 shipments · $1.41 | |||||||||||
| 52 | Dec 2025 | UNLISTED BUYER | Barbados | Injection | 50 | NOS | $0.028 | $1.41 | MUMBAI AIR (SAHAR) | BRIDGETOWN | AIR |
| SUPPLIER #22 — DISTINCT IMPEX PVT LTD · 2 shipments · $0.592 | |||||||||||
| 53 | Dec 2025 | UNLISTED BUYER | Jamaica | Injection | 20 | NOS | $0.0097 | $0.194 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
| 54 | Dec 2025 | UNLISTED BUYER | Jamaica | Tablet | 100 | NOS | $0.0040 | $0.399 | MUMBAI AIR (SAHAR) | KINGSTON | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 2 shipments · $239.58 · 1 Indian suppliers · 2 buyers
SHIPMENTS
2
USD
$239.58
COUNTRIES
1
SUPPLIERS
1
BUYERS
2
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea (100.0%)
$239.58
Top 1 Indian suppliers into Oceania
1
KAMAL INTERNATIONAL DIVISION OF GAJHAM EXPORTS PRI
$239.58
Top 0 Oceania importers
Top 1 dosage forms
1
Injection
$239.58
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 2 | $239.58 | $119.79 |
| Dec | 0 | $0.0000 | — |
Shipment register · 2 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — KAMAL INTERNATIONAL DIVISION OF GAJHAM EXPORTS PRI · 2 shipments · $239.58 | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Papua New Guinea | Injection | 100 | NOS | $1.20 | $119.79 | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
| 2 | Nov 2025 | UNKNOWN BUYER | Papua New Guinea | Injection | 100 | NOS | $1.20 | $119.79 | MUMBAI AIR (SAHAR) | PORT MORESBY | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 78 Indian cyclophosphamide exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped cyclophosphamide in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LTD | MEDCHAL MALKAJIGIRI DIST | 4 | $2.66M | Injection | Americas |
| 2 | ALEMBIC PHARMACEUTICALS LTD | GUJARAT | 2 | $106K | Capsule | Americas |
| 3 | KWALITY PHARMACEUTICALS LTD | AMRITSAR | 7 | $51K | Injection, Tablet | Europe, Asia |
| 4 | AMRS HEALTHCARE PVT LTD | NOIDA | 2 | $27K | Injection | Americas |
| 5 | PEACOCK MEDICINE COMPANY | NEW DELHI | 1 | $23K | Injection | Africa |
| 6 | GETWELL PHARMA INDIA PVT LTD | GURGAON | 13 | $16K | Injection | Asia, Africa |
| 7 | INDOCO REMEDIES LTD | BADDI | 4 | $16K | Tablet, Suspension | Asia |
| 8 | SUBHRA PHARMA PRIAVATE LTD | Navghar Mulund East Mumbai | 4 | $7K | Tablet | Americas, Africa |
| 9 | MYGENIC HEALTHCARE PVT LTD | NAVI MUMBAI | 7 | $7K | Tablet, Injection | Americas |
| 10 | UNITED BIOTECH PVT LTD | NEW DELHI | 5 | $5K | Injection | Asia, Americas |
| 11 | ARYSON HEALTHCARE PVT LTD | AHMEDNAGAR | 1 | $3K | Injection | Asia |
| 12 | ZUVIUS LIFESCIENCES PVT LTD | GHATKOPAR (E) | 6 | $2K | Injection | Africa |
| 13 | S P AND COMPANY | MUMBAI | 6 | $2K | Injection | Africa |
| 14 | SALVAVIDAS PHARMACEUTICAL PVT LTD | SURAT | 1 | $2K | Tablet | Asia |
| 15 | TRIKAYA GLOBAL | MUMBAI | 2 | $2K | Injection | Asia |
| 16 | AARIA PHARMACEUTICALS PVT LTD | VADODARA | 1 | $2K | Tablet | Africa |
| 17 | VAMA HEALTH WORLD LLP | Mumbai | 9 | $2K | Injection, Tablet | Americas, Africa |
| 18 | MATHI ASSOCIATES | MUMBAI | 1 | $1K | Injection | Africa |
| 19 | MALLESHWAR SPECIALITIES | BANGALORE | 3 | $1K | Tablet | Asia |
| 20 | KLV HEALTHCARE PVT LTD | DAHISAR | 2 | $1K | Injection | Africa |
| 21 | CHAWLA MEDICOS | NEW DELHI | 1 | $989.76 | Africa | |
| 22 | KERK | DELHI | 2 | $965.88 | Tablet | Asia |
| 23 | REGALIA LIFE SCIENCE PVT LTD | PUNE | 14 | $760.08 | Injection | Asia |
| 24 | SANSKRUTI PHARMA | SURAT | 6 | $739.43 | Injection | Africa |
| 25 | DOSSMEGT PHARMACEUTICALS PVT LTD | MULUND WEST | 3 | $703.41 | Injection | Asia, Americas |
| 26 | MEDINEX HEALTHCARE | Mumbai | 3 | $610.35 | Tablet, Vial | Americas |
| 27 | RMPL PHARMA LLP | MUMBAI | 4 | $550.83 | Tablet, Injection | Asia, Africa |
| 28 | MENAMED PHARMA PVT LTD | DELHI | 2 | $542.41 | Injection | Africa |
| 29 | S. HIMATLAL HEALTHCARE LLP | MUMBAI | 3 | $478.20 | Injection | Asia, Africa |
| 30 | R.S. SURGIPHARM PVT LTD | AHMEDABAD | 2 | $471.27 | Injection, Tablet | Africa |
| 31 | LIFENEST PHARMA LLP | Mumbai | 1 | $432.31 | Other | Africa |
| 32 | WELLKIND PHARMACEUTICAL PVT LTD | MUZAFFARANAGAR | 2 | $421.92 | Injection | Africa |
| 33 | MATOSHREE HEALTH CARE PVT LTD | THAKURDWAR MUMBAI | 1 | $404.74 | Injection | Africa |
| 34 | DROPS PHARMA PVT LTD | HOSDURG | 7 | $398.36 | Tablet, Injection | Asia |
| 35 | ANINS HEALTHCARE PVT LTD | CHANDIGARH | 1 | $382.47 | Powder | Americas |
| 36 | LEOWIN HEALTHCARE LLP | GANDHINAGAR | 1 | $375.85 | Injection | Asia |
| 37 | ATLAS ENTERPRISES | NAGPUR | 3 | $368.14 | Powder | Americas |
| 38 | VANDAN HEALTHCARE | AHMEDABAD | 1 | $364.32 | Injection | Asia |
| 39 | MEDEX PHARMACEUTICALS | KULASEKHARAM POST | 6 | $310.47 | Injection | Asia |
| 40 | BAKER & DAVIS PVT LTD | MUMBAI | 1 | $297.51 | Tablet | Asia |
| 41 | VINCCENT BIOTECH PVT LTD | DELHI | 2 | $257.32 | Injection | Africa |
| 42 | RUTVA MEDICARE | SURAT | 8 | $241.86 | Africa | |
| 43 | KAMAL INTERNATIONAL DIVISION OF GAJHAM EXPORTS PRI | MUMBAI | 2 | $239.58 | Injection | Oceania |
| 44 | PIRZE LIFECARE PVT LTD | AHMEDABAD | 3 | $193.67 | Injection | Africa |
| 45 | ZYPHARS PHARMACEUTICS PVT LTD | PUNE | 3 | $185.69 | Tablet | Europe, Asia |
| 46 | J.A. UNITED EXPORTS PVT LTD | VASHI | 4 | $179.57 | Injection | Asia, Africa |
| 47 | BRUCK PHARMA PVT LTD | NANI | 1 | $154.59 | Injection | Africa |
| 48 | M T MADON EXPORTS | MUMBAI | 2 | $149.81 | Injection | Africa |
| 49 | MDS ENTERPRISES | MUMBAI | 5 | $141.43 | Injection | Africa, Asia |
| 50 | PHARMA CHOICE LLP | MULUND EAST | 2 | $140.89 | Tablet | Asia |
| 51 | SARA TRADING CORP | JABALPUR | 3 | $124.30 | Tablet | Americas |
| 52 | JMB PHARMACEUTICALS PVT LTD | MUMBAI | 5 | $92.08 | Injection | Asia |
| 53 | WORLDPRIME EXPORT LLP | JUNAGADH | 1 | $81.59 | Injection | Africa |
| 54 | PLEASANT EXPORTS | CHENNAI | 1 | $69.43 | Tablet | Asia |
| 55 | TIGER REMEDIES | SURAT | 1 | $65.89 | Tablet | Americas |
| 56 | MEDMATRIX ASSOCIATES | AMBALA | 1 | $61.22 | Tablet | Asia |
| 57 | TOVEC PHARMA PVT LTD | SURAT | 1 | $52.12 | Injection | Americas |
| 58 | 3S CORP | MUMBAI | 1 | $48.36 | Tablet | Africa |
| 59 | AKSHAR PHARMA | SURAT | 2 | $39.59 | Injection | Americas |
| 60 | GOLDFIELD HEALTHCARE | Mumbai | 1 | $38.02 | Injection | Africa |
| 61 | RUN MEDWAY | SURAT | 1 | $30.60 | Tablet | Africa |
| 62 | PARKSLEY GLOBAL PVT LTD | Pune | 1 | $27.60 | Injection | Americas |
| 63 | BIOZENTA LIFESCIENCE PVT LTD | Una | 3 | $27.12 | Tablet, Injection | Africa |
| 64 | MEDMALL PHARMACY PVT LTD | Hyderabad | 1 | $25.03 | Tablet | Asia |
| 65 | DM WORLDWIDE TRADING | MAHESANA | 1 | $24.75 | Injection | Africa |
| 66 | NARAYANA HRUDAYALAYA LTD | BANGALORE | 3 | $22.99 | Injection | Americas |
| 67 | NU HOSPITALS PVT LTD | BENGALURU | 1 | $18.99 | Injection | Asia |
| 68 | MEDICOS LIFESCIENCES | AHMEDABAD | 1 | $17.90 | Injection | Africa |
| 69 | AL-ROYAL PHARMACEUTICAL PVT LTD | NEW DELHI | 1 | $14.66 | Injection | Africa |
| 70 | FLORENCIA HEALTHCARE | NOIDA | 1 | $8.54 | Tablet | Americas |
| 71 | AZKA MEDTRADE AND SERVICES | MUMBAI | 1 | $7.40 | Injection | Africa |
| 72 | V. S. HEALTHCARE | AHMEDABAD | 1 | $6.33 | Injection | Africa |
| 73 | MELON GLOBALCARE | MUMBAI | 2 | $5.74 | Injection, Tablet | Africa |
| 74 | MBA PHARMACEUTICALS PVT LTD | DELHI | 1 | $3.59 | Injection | Africa |
| 75 | DISTINCT IMPEX PVT LTD | MUMBAI | 4 | $3.33 | Injection, Tablet | Americas, Asia |
| 76 | HSCC (INDIA) LTD | NOIDA | 2 | $2.45 | Tablet, Powder for Injection | Africa |
| 77 | BRINTON PHARMACEUTICALS LTD | PUNE | 1 | $1.41 | Injection | Americas |
| 78 | ZIL PHARMA | MUMBAI | 1 | $0.118 | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 59 global cyclophosphamide importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian cyclophosphamide in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | EUGIA US LLC | United States | 4 | $2.66M | EUGIA PHARMA SPECIAL… | Injection |
| 2 | J. KNIPPER & COMPANY | United States | 2 | $106K | ALEMBIC PHARMACEUTIC… | Capsule |
| 3 | PHARMACIE POPULAIRE DU MALI | Mali | 1 | $23K | PEACOCK MEDICINE COM… | Injection |
| 4 | ACCESORIOS SUMINISTROS Y EQUIPO MED | Mexico | 1 | $21K | KWALITY PHARMACEUTIC… | Injection |
| 5 | BIRGANJ MEDI SA | Nepal | 4 | $16K | INDOCO REMEDIES LTD | Tablet, Suspension |
| 6 | TRUST ANESTHETIC LTD | Afghanistan | 3 | $14K | KWALITY PHARMACEUTIC… | Injection, Tablet |
| 7 | CENTRALE DACHATS DE MEDICAMENTS | Madagascar | 2 | $8K | GETWELL PHARMA INDIA… | Injection |
| 8 | DITA ESTFARM LLC | Moldova | 2 | $8K | KWALITY PHARMACEUTIC… | Injection |
| 9 | AMBICA INTERNATIONAL CORP | Philippines | 1 | $5K | GETWELL PHARMA INDIA… | |
| 10 | CORPORACION FARMACEUTICA DE C.A.S.A | Nicaragua | 2 | $5K | UNITED BIOTECH PVT LTD | Injection |
| 11 | IC PHARMA LAO CO LTD | Laos | 1 | $3K | ARYSON HEALTHCARE PV… | Injection |
| 12 | DOMAKS INVESTMENT LTD | Nigeria | 4 | $2K | ZUVIUS LIFESCIENCES … | Injection |
| 13 | MOG LOGISTICS LLC | Egypt | 1 | $2K | AARIA PHARMACEUTICAL… | Tablet |
| 14 | AS PER INVOICE MEXICO | Mexico | 7 | $2K | VAMA HEALTH WORLD LLP | Injection, Tablet |
| 15 | PHARMACHEIME LTD | Malawi | 1 | $1K | MATHI ASSOCIATES | Injection |
| 16 | RECHARGED DISTRIBUTORS LTD | Jamaica | 2 | $1K | GETWELL PHARMA INDIA… | Injection |
| 17 | RENATO C LOZADA | Philippines | 3 | $1K | MALLESHWAR SPECIALIT… | Tablet |
| 18 | VISION CARE INTERNATIONAL PVT LTD | Nepal | 3 | $1K | GETWELL PHARMA INDIA… | Injection |
| 19 | MUBARAK HASHIMI LTD | Afghanistan | 2 | $965.88 | KERK | Tablet |
| 20 | AUTOMOBILE TRANSPORTATION SERVICES | Lebanon | 1 | $952.88 | TRIKAYA GLOBAL | Injection |
| 21 | TO THE PURCHASE MANAGER IMPORT DEPA | United Arab Emirates | 14 | $760.08 | REGALIA LIFE SCIENCE… | Injection |
| 22 | PHILTA PHARMACY AND HEALTHCARE | Ghana | 1 | $432.31 | LIFENEST PHARMA LLP | Other |
| 23 | NEW AFRICA SOFTWARE SOLUTION LTD | Ghana | 2 | $421.92 | WELLKIND PHARMACEUTI… | Injection |
| 24 | NIKHIL PHARMA PVT LTD | Nepal | 3 | $393.96 | UNITED BIOTECH PVT LTD | Injection |
| 25 | GP AVIS AGENCIES INC | Barbados | 1 | $382.47 | ANINS HEALTHCARE PVT… | Powder |
| 26 | DISTRIBUIDORA MEDICA PAREDES S.DE | Mexico | 1 | $359.59 | ATLAS ENTERPRISES | |
| 27 | RAPATI ENTERPRISES | Singapore | 1 | $297.51 | BAKER & DAVIS PVT LTD | Tablet |
| 28 | NOVO GENERAL TRADING FZE | United Arab Emirates | 1 | $259.56 | DOSSMEGT PHARMACEUTI… | Injection |
| 29 | MEDIMART DRUG STORE | United Arab Emirates | 2 | $211.06 | DROPS PHARMA PVT LTD | Tablet, Injection |
| 30 | CENTRAIMED | Equatorial Guinea | 3 | $193.67 | PIRZE LIFECARE PVT LTD | Injection |
| 31 | HOPITAL CARAMED CLINIQUE DU CANCE | Haiti | 1 | $184.30 | DOSSMEGT PHARMACEUTI… | Injection |
| 32 | AL-NOOR FOR DRUGS & MEDICAL APPLIAN | Yemen | 4 | $179.57 | J.A. UNITED EXPORTS … | Injection |
| 33 | BEST INTERNATIONAL FZE | United Arab Emirates | 3 | $155.23 | MEDEX PHARMACEUTICALS | Injection |
| 34 | SALAMA PHARMACUTICALS LTD | Kenya | 1 | $144.81 | M T MADON EXPORTS | Injection |
| 35 | RADEEP SERVICES | Singapore | 2 | $140.89 | PHARMA CHOICE LLP | Tablet |
| 36 | AFRICURE PHARMACEUTICALS BURKINA SA | Burkina Faso | 1 | $128.66 | VINCCENT BIOTECH PVT… | Injection |
| 37 | TSOMBO LLC | Mongolia | 1 | $106.38 | GETWELL PHARMA INDIA… | Injection |
| 38 | DALIAN CHAOHONGSUPPLY CHAIN MANAGEM | China | 1 | $92.08 | JMB PHARMACEUTICALS … | Injection |
| 39 | THE ESSES PHARMACY (PVT) LTD | Sri Lanka | 1 | $69.43 | PLEASANT EXPORTS | Tablet |
| 40 | GULF IMPEX FZC | Afghanistan | 1 | $61.22 | MEDMATRIX ASSOCIATES | Tablet |
| 41 | CARIMED TRADING | Saint Lucia | 1 | $53.18 | SARA TRADING CORP | Tablet |
| 42 | FOR THE ORDER OF | Kenya | 1 | $48.36 | 3S CORP | Tablet |
| 43 | CLYZ PHARMA SARL | Cameroon | 1 | $30.60 | RUN MEDWAY | Tablet |
| 44 | A LA ORDEN DE FACTURA LEVANTADA A | Saint Lucia | 1 | $27.60 | PARKSLEY GLOBAL PVT … | Injection |
| 45 | PRISM INTERNATIONAL LLC | Sri Lanka | 1 | $25.03 | MEDMALL PHARMACY PVT… | Tablet |
| 46 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | 3 | $22.99 | NARAYANA HRUDAYALAYA… | Injection |
| 47 | INDIRA GANDHI MEMOROAL HOSPITAL | Maldives | 1 | $18.99 | NU HOSPITALS PVT LTD | Injection |
| 48 | VANTERPOOL ENTERPRISES LTD | British Virgin Islands | 1 | $17.93 | SARA TRADING CORP | Tablet |
| 49 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | 1 | $17.90 | MEDICOS LIFESCIENCES | Injection |
| 50 | ROYAL PHARMA COMPANY | Egypt | 1 | $14.66 | AL-ROYAL PHARMACEUTI… | Injection |
| 51 | DISTRIBUIDORA MEDICA PAREDES S.DE R | Mexico | 2 | $8.54 | ATLAS ENTERPRISES | Powder |
| 52 | COPTIC ORTHODOX CHURCH / COPTIC | Zambia | 1 | $6.33 | V. S. HEALTHCARE | Injection |
| 53 | SUNCREST INTERNATIONAL LTD | Trinidad and Tobago | 2 | $5.19 | GETWELL PHARMA INDIA… | |
| 54 | MOHAMED AHEMED MOHAMUD | Somalia | 1 | $5.00 | M T MADON EXPORTS | Injection |
| 55 | AS PER INVOICE GHANA | Ghana | 2 | $2.79 | VAMA HEALTH WORLD LLP | Injection |
| 56 | DR (MS.) LEIA MONTEIRO, DIRECTOR | Mozambique | 1 | $2.45 | HSCC (INDIA) LTD | Tablet |
| 57 | HANITRA RAZAOARIMANANA | Madagascar | 2 | $1.90 | GETWELL PHARMA INDIA… | Injection |
| 58 | TO,THE ORDER OF | United Arab Emirates | 1 | $0.146 | ZYPHARS PHARMACEUTIC… | Tablet |
| 59 | DR(MS)LEIA MONTEIRO DIRECTOR | Mozambique | 1 | $0.0000 | HSCC (INDIA) LTD | Powder for Injection |
This report covers 221 2025-Q4 Cyclophosphamide shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/cyclophosphamide
Talk to our trade analyst
Need a custom cyclophosphamide report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/cyclophosphamide
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Cyclophosphamide product page
Live data, supplier directory, price trends, and trade route analysis